This trial is conducted in China. This study is a randomized, single-center, open, three-period crossover trial in healthy subjects to compare the PK, PD, and safety of a single administration of GZR4 at different injection sites (abdomen, deltoid region of upper arm, and thigh).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
24
GZR4 Injection administered sc, once weekly.
Study Site
Beijing, China
RECRUITINGAUC0-672h
Area Under the Concentration Versus Time Curve of GZR4 Injection From Time Zero to 672 hours
Time frame: From Predose to 672 hours after a single dose
AUC0-∞
Area Under the Concentration Versus Time Curve of GZR4 Injection From Time Zero to Infinity
Time frame: From Predose to 672 hours after a single dose
Cmax
Maximum Concentration of GZR4 Injection
Time frame: From Predose to 672 hours after a single dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.